Riccardo Gherli
A5004893991- Cardiac Valve Diseases and Treatments
- Cardiac, Anesthesia and Surgical Outcomes
- Cardiac and Coronary Surgery Techniques
- Infective Endocarditis Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Aortic Disease and Treatment Approaches
- Aortic aneurysm repair treatments
- Cardiac Structural Anomalies and Repair
- Mechanical Circulatory Support Devices
- Venous Thromboembolism Diagnosis and Management
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Cardiac Arrest and Resuscitation
- Coronary Interventions and Diagnostics
- Cerebrovascular and Carotid Artery Diseases
- Blood transfusion and management
- Streptococcal Infections and Treatments
- Atrial Fibrillation Management and Outcomes
- Acute Kidney Injury Research
- Surgical site infection prevention
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Cardiovascular Health and Disease Prevention
- Intracranial Aneurysms: Treatment and Complications
- Cardiac Imaging and Diagnostics
- Infectious Aortic and Vascular Conditions
Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo
2020-2023
Nini Hospital
2016-2022
Carlo Forlanini Hospital
2015-2020
Glenfield Hospital
2015-2018
Istituto Superiore di Sanità
2018
Azienda Ospedaliero Universitaria Ospedali Riuniti
2018
IRCCS San Camillo Hospital
2015-2018
Azienda Ospedaliera San Camillo-Forlanini
2018
Clínica Girona
2018
Magna Graecia University
2018
Clinical evidence in coronary surgery is usually derived from retrospective, single institutional series. This may introduce significant biases the analysis of critical issues treatment these patients. In order to avoid such methodological limitations, we planned a European multicenter, prospective study on artery bypass grafting, E-CABG registry. The registry multicenter and its data are prospectively collected 13 centers cardiac university community hospitals located six countries...
Early studies of the Tendyne transcatheter mitral valve replacement (TMVR) showed promising results in a small selective cohort. The authors present 1-year data from currently largest commercial, real-world cohort originating investigator-initiated TENDER (Tendyne European Experience) registry. All patients registry eligible for follow-up were included. primary safety endpoint was cardiovascular mortality. Primary performance reduction regurgitation (MR) up to 1 year. Among 195 undergoing...
The aim of this study was to assess the impact frailty on outcome after coronary artery bypass grafting (CABG) and whether it may improve predictive ability European System for Cardiac Operative Risk Evaluation (EuroSCORE II).The Clinical Frailty Scale (CFS) assessed preoperatively in patients undergoing isolated CABG from multicentre E-CABG registry, were stratified into 3 classes: scores 1-2, 3-4 5-7.Of 6156 enrolled, 39.2% had CFS 57.6% 3-4, 3.2% 5-7. Logistic regression adjusted multiple...
The optimal timing of discontinuation ticagrelor before cardiac surgery is controversial.To evaluate the safety preoperative use with or without aspirin in patients acute coronary syndromes (ACS) undergoing isolated artery bypass grafting (CABG) compared alone.This prospective, multicenter clinical trial was performed at 15 European centers surgery. Participants were ACS CABG from Multicenter Study on Coronary Artery Bypass Grafting (E-CABG) registry between January and September 2015.Before...
Background:Glycated hemoglobin (HbA1c) is a suspected risk factor for sternal wound infection (SWI) after CABG.
BACKGROUND Excessive bleeding and blood transfusion are associated with adverse outcome after cardiac surgery, but their mechanistic effects difficult to disentangle in patients increased operative risk. This study aimed evaluate the incidence prognostic impact of products low‐risk undergoing coronary artery bypass grafting (CABG). STUDY DESIGN AND METHODS Sixteen tertiary European centers surgery contributed prospective registry CABG (E‐CABG). The severity was defined by E‐CABG...
The impact of thrombocytopenia on postoperative bleeding and other major adverse events after cardiac surgery is unclear. This issue was investigated in a series patients who underwent isolated coronary artery bypass grafting (CABG) from the prospective, multicenter E-CABG registry. Preoperative defined as preoperative platelet count <150 × 109/L it considered moderate-severe when <100 109/L. Multilevel mixed-effects regression analysis performed to adjust effect outcomes for baseline...
No data exists on inter-institutional differences in terms of adherence to international guidelines regarding the discontinuation antithrombotics and rates severe bleeding coronary artery bypass grafting (CABG). This is an analysis 7118 patients from prospective multicentre European CABG (E-CABG) registry who underwent isolated 15 centres. Preoperative pause P2Y12 receptor antagonists shorter than that suggested by 2017 ESC (overall 11.6%) ranged 0.7% 24.8% between centres (adjusted P <...